A resident of San Juan, Puerto Rico, Warren B. Lammert has professional interests in finance, investing, epilepsy, and philanthropy. Outside of his role at Granite Point Capital, Warren Lammert serves as Chairman of Tevard Biosciences. Other companies where he has served in supervisory roles include Engage Therapeutics acquired by UCB and Biscayne Neurotherapeutics acquired by Supernus Pharmaceuticals. His professional interests in finance and investing include understanding innovation, the history of finance and economics, investment and capital management, venture capital, behavioral economics and finance and European and Chinese economic history. His work in philanthropy has included leadership roles as board member and chairman of the national Epilepsy Foundation, as Founder and Chairman of the Epilepsy Therapy Project and as an advisory board member of the NYU based Finding a Cure for Epilepsy and Seizures (FACES). Mr. Lammert has also supported other startups in the epilepsy therapeutic and diagnostic space. Mr. Lammert maintains a membership in the American Epilepsy Society.